⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote
businesswire.com
TEVA
Liposomal Doxorubicin Market Insights Report 2026: Cancer Incidence Surge Fuels Market Growth, Asia-Pacific Emerges as Fastest-Growing Region
globenewswire.com
JNJ
PFE
TEVA
Sorafenib Market Research Report 2026-2030 - Increasing Cancer Incidence Spurs Sorafenib Market Expansion
globenewswire.com
TEVA
Capecitabine Market Outlook 2026-2030 Shows 9% CAGR as Innovations in Therapies and Homecare Treatment Adoption Accelerate Industry Growth
globenewswire.com
TEVA
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
globenewswire.com
TEVA
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
globenewswire.com
JNJ
MRK
ABBV
ABT
NVS
GSK
AMGN
TEVA
JAGX
LLY
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB
EIB Waives its Right to Cash Settlement on Medincell Warrants
businesswire.com
TEVA
La BEI renonce à son droit au règlement en cash de ses BSA Medincell
businesswire.com
TEVA
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)
globenewswire.com
TEVA